• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Carotid and femoral bruits as cardiovascular risk indicators in a middle-aged Finnish population

byDavy LauandAlex Chan
December 13, 2022
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients with auscultated carotid and femoral bruits were found to have an elevated risk for cardiovascular (CV) mortality, but after excluding patients with a history of CV events, no association was found between bruits and CV events or all-cause mortality.

Evidence Rating Level: 2 (Good)

As the leading cause of death globally, predicting the risk of cardiovascular (CV) disease-related adverse events is pertinent. While there are risk calculators available and complex measurements such as carotid intima-media thickness, the utility of less complex clinical tests, such as assessing for carotid or femoral bruits, has not been rigorously studied. Therefore, this 20-year prospective study examined the association between carotid and femoral bruits and mortality from CV disease and all causes. The study population consisted of participants randomly chosen from the Social Insurance Institute of Finland: This included 600 patients with hypertension who were matched by age and sex to 600 other subjects. The auscultation for bruits was done in the early 1990s, and patients were followed for 20 years until 2014. In total, there were 1045 subjects, 49.8% of whom were male, and with a mean (SD) age of 51.3 (5.97) years at the beginning of the study. Also, 4.0% had carotid bruits, 11.9% had femoral bruits, 1.1% had both, and 85.2% had neither. The results found that 23.1% of participants died, and 34.0% of those deaths were CV related. Both carotid and femoral bruits were associated with higher risk of CV-related death (hazards ratio 4.15, 95% CI 2.39-8.52, p < 0.001; HR 2.55, 95% CI 1.54-4.22, p < 0.001 respectively). The incidence of mortality from CV events was 1.48% per person-year for those with carotid bruits, 0.81% per person-year for those with femoral bruits, and 0.82% per person-year for those with either. After adjustments for CV risk factors such as blood pressure, smoking, cholesterol levels, and history of coronary disease or stroke, the risk for CV deaths was increased by 69% for patients with a carotid or femoral bruit, compared to those without. However, when excluding patients with prior CV events, there was no association between carotid and femoral bruits with future CV event or all-cause mortality. Overall, this study found that there is an elevated risk of CV-related death for middle-age patients with carotid and femoral bruits, but without a history of a prior CV event, bruits were not associated with future CV events or all-cause mortality.

Click to read the study in PLOSONE

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Atopic dermatitis activity is not associated with cardiovascular risk

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Tags: bruitscardiologycardiovascular riskchronic disease
Previous Post

Monofilament suture does not reduce pregnancy loss compared to braided suture for cervical cerclage

Next Post

COVID-19 increased anxiety rates during the perinatal period and pregnancy

RelatedReports

Eczema more prevalent among older adults than previously thought
Cardiology

Atopic dermatitis activity is not associated with cardiovascular risk

April 2, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

April 2, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
Next Post
2 Minute Rewind November 29, 2021

COVID-19 increased anxiety rates during the perinatal period and pregnancy

#VisualAbstract: Bepirovirsen may reduce disease burden in patients with chronic hepatitis B

#VisualAbstract: Bepirovirsen may reduce disease burden in patients with chronic hepatitis B

Artifical cornea is well-retained in patients with ocular surface disease

Prevalence of keratoconus estimated at more than 3%

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prednisone may have bone and cardiovascular benefits compared to hydrocortisone therapy in adrenal insufficiency
  • Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial
  • Early surgical valve replacement offers survival benefit in asymptomatic, very severe aortic stenosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.